血清淀粉样蛋白A与类风湿关节炎的关联:系统评价与荟萃分析
该系统评价与荟萃分析纳入截至2021年5月的33项研究(3524例类风湿关节炎患者和3537名正常对照),发现类风湿关节炎组血清淀粉样蛋白A水平显著高于对照组(SMD=0.80,95%CI 0.51~1.08),且SAA水平随类风湿关节炎病情加重而逐渐升高;SAA与DAS28、ESR、CRP、RF、IL-4、IL-6、IL-10、IL-17及A-CCP呈正相关,与血红蛋白呈负相关;SAA 1.3等位基因及SAA 1.3/1.3基因型与类风湿关节炎及类风湿关节炎伴淀粉样变性风险相关。
要点
- 类风湿关节炎组SAA水平显著高于对照组,SMD=0.80(95%CI 0.51~1.08)。
- SAA浓度随类风湿关节炎病情加重而逐渐升高。
- SAA 1.3等位基因与类风湿关节炎风险相关(OR=1.30,95%CI 1.02~1.65)。
核心结论
- 高水平的SAA可能与类风湿关节炎风险升高相关,且SAA浓度可能随类风湿关节炎病情加重而逐渐升高。
- 高水平的SAA可能通过增强DAS28、ESR、CRP、RF、IL-4、IL-6、IL-10、IL-17和A-CCP水平或降低血红蛋白水平在类风湿关节炎中发挥重要作用。
- SAA 1.3等位基因和SAA 1.3/1.3基因型可能是类风湿关节炎及类风湿关节炎伴淀粉样变性的危险因素。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Cochrane Library、Embase和中国知网(CNKI)数据库截至2021年5月的文献。
- 共纳入33项研究,涉及3524例类风湿关节炎患者和3537名正常对照。
主要发现
- 类风湿关节炎组SAA水平显著高于对照组,SMD=0.80(95%CI 0.51~1.08)。
- 分层分析显示SAA浓度随类风湿关节炎病情加重而逐渐升高。
- SAA水平与DAS28呈正相关(r=0.55,95%CI 0.15~0.94),与ESR呈正相关(r=0.65,95%CI 0.53~0.76),与CRP呈正相关(r=0.92,95%CI 0.57~1.57)。
- SAA水平与RF呈正相关(r=0.24,95%CI 0.09~0.39),与IL-4呈正相关(r=0.54,95%CI 0.30~0.78),与IL-6呈正相关(r=0.46,95%CI 0.27~0.65)。
- SAA水平与IL-10呈正相关(r=0.53,95%CI 0.29~0.77),与IL-17呈正相关(r=0.52,95%CI 0.27~0.77),与A-CCP呈正相关(r=0.32,95%CI 0.15~0.50),与血红蛋白呈负相关(r=-0.51,95%CI -0.84~-0.18)。
关键数值与推荐
- SAA 1.3等位基因与类风湿关节炎风险相关(OR=1.30,95%CI 1.02~1.65),与类风湿关节炎伴淀粉样变性风险相关(OR=2.06,95%CI 1.63~2.60)。
- SAA 1.3/1.3基因型与类风湿关节炎风险相关(OR=1.56,95%CI 1.00~2.43),与类风湿关节炎伴淀粉样变性风险相关(OR=4.47,95%CI 2.70~7.41)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: Consistent correlation of serum amyloid A (SAA) to rheumatoid arthritis (RA) is not completely established. The present study is to systematically summarize their relationship. METHODS: Publications up to may 2021 were examined using key terms in the PubMed, Cochrane Library, Embase and China national knowledge infrastructure (CNKI) databases. RESULTS: The total 33 studies, involving in 3524 RA cases and 3537 normal participants, were included. The pooled result indicated that the SAA level in the RA group was markedly higher than that in the control group [standardized mean difference (SMD) = 0.80, 95% CI (0.51, 1.08)]. By stratified analyses, the concentration of SAA was found to be gradually increased with the aggravation of RA. Additionally, the meta-analysis of correlation demonstrated that SAA levels were positively associated with the levels of disease activity score 28 (DAS28) [r = 0.55, 95% CI (0.15, 0.94)], erythrocyte sedimentation rate (ESR) [r = 0.65, 95% CI (0.53, 0.76)], C-reactive protein (CRP) [r = 0.92, 95% CI (0.57, 1.57)], rheumatoid factor (RF) [r = 0.24, 95% CI (0.09, 0.39)], interleukin 4 (IL-4) [r = 0.54, 95% CI (0.30, 0.78)], interleukin 6 (IL-6) [r = 0.46, 95% CI (0.27, 0.65)], interleukin 10 (IL-10) [r = 0.53, 95% CI (0.29, 0.77)], interleukin 17 (IL-17) [r = 0.52, 95% CI (0.27, 0.77)], and anti-cyclic citrullinated peptide antibody (A-CCP) [r = 0.32, 95% CI (0.15, 0.50)], but inversely linked with the levels of hemoglobin [r=-0.51, 95% CI (-0.84, -0.18)]. Furthermore, the allele of SAA 1.3 was actively related with increased risks of RA [OR=1.30, 95% CI (1.02, 1.65)] and of RA with amyloidosis [OR=2.06, 95% CI (1.63, 2.60)]. Besides, the genotype of SAA 1.3/1.3 was positively connected with the risks of RA [OR=1.56, 95% CI (1.00, 2.43)] and of RA with amyloidosis [OR=4.47, 95% CI (2.70, 7.41)]. CONCLUSIONS: High levels of SAA might be associated with elevated risk of RA, and the concentration of SAA might be gradually increased with the aggravation of RA. Moreover, high levels of SAA might play a vital role in RA by enhancing the levels of DAS28, ESR, CRP, RF, IL-4, IL-6, IL-10, IL-17 and A-CCP, or by attenuating hemoglobin levels. More importantly, the allele of SAA 1.3 and genotype of SAA 1.3/1.3 might be the risk factor of RA and of RA with amyloidosis.
引用
- Zhou J, Dai Y, Lin Y, et al. Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2021. PMID: 35027248. doi:10.1016/j.semarthrit.2021.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。